A share-placing by the Leeds-based biotechnology company Tissue Regenix has raised £25 million to support its research and development work in tissue engineering techniques.
Founded by two senior University of Leeds researchers, John Fisher and Eileen Ingham, the company holds licences on patents resulting from research funded by the Engineering and Physical Sciences Research Council.
This article on Research Professional News is only available to Research Professional or Pivot-RP users.
Research Professional users can log in and view the article via this link
Pivot-RP users can log in and view the article via this link.